1. TDAG8 (GPR65) gene expression is down-regulated in hematological malignancies.
Introduction
In the early twentieth century Otto Warburg recognized a metabolic phenomenon that occurred in cancer cells, currently known as the Warburg Effect 1-4 . Warburg discovered cancer cells favor glycolysis rather than oxidative phosphorylation for energy production, even in the presence of oxygen [1] [2] [3] [4] . It was originally hypothesized that irreversible injury of mitochondrial respiration is the cause of cancer cell formation 1 . However, this hypothesis was to some extent discredited as most cancers retain their ability to exploit mitochondrial respiration, although to a lesser degree than normal cells [5] [6] [7] . As a result of unrestricted glycolysis the tumor microenvironment is spatially acidic [8] [9] [10] . Extracellular acidosis has pleiotropic effects on tumor growth and cancer progression [10] [11] [12] [13] [14] . Tumor acidosis can stimulate cell death, reduce cell proliferation, and induce chromosomal instability of normal somatic cells and cancer cells [13] [14] [15] [16] .
In addition, tumor cells that become resistant to extracellular acidosis have been reported more malignant and invasive 17, 18 . Therefore, extracellular tumor acidosis augments cancer progression in a Darwinian manner worsening disease prognosis. As such, it is imperative to understand how tumor cells sense and respond to acidic surroundings for adequate comprehension of cancer development.
T cell death-associated gene 8 (TDAG8, also known as GPR65) is a member of the proton sensing G-protein coupled receptor family, which also includes GPR4, GPR68 (OGR1), and GPR132 (G2A). The family of G-protein coupled receptors is activated by extracellular acidosis, which illuminates a receptor signaling connection to the acidic conditions found in tumor microenvironment 19 . The human TDAG8 gene has been mapped to chromosome 14q31-32.1, a location that abnormalities associated with T cell lymphoma and leukemia are found and is primarily expressed in immune cells and leukocyte-rich tissues such as circulating peripheral leukocytes, spleen, thymus, and tonsils 20, 21 . TDAG8 has been reported to have both pro-and anti-oncogenic effects in blood cancers, which indicate TDAG8 effects are cell type and context dependent [22] [23] [24] . Therefore, it is imperative to understand the contextual effects of TDAG8 in hematological malignancies. Blood cancer cells are generally glycolytic and produce lactic acid that can acidify the microenvironment. Some types of hematological malignancies, such as lymphomas, have the ability to form solid tumors in which the tumor microenvironment is acidic. Other types of hematological malignancies, such as leukemia and multiple myeloma, form in and metastasize to bone marrow that has hypoxic and possibly acidic niches 25, 26 . In rare cases, systemic lactic acidosis occurs in patients with hematological malignancies and is associated with poor prognosis 27 .
In this study the effects of acidosis and TDAG8 gene expression was investigated in blood cancers. TDAG8 gene expression was examined in hematological malignancies revealing a significant reduction in comparison to normal immune cells and leukocyte-rich tissues.
Functional studies demonstrated that restoration of TDAG8 gene expression suppressed the growth, migration and metastasis of blood cancer cells and sensitized them to extracellular acidosis.
Materials and Methods

Bioinformatics
TDAG8 gene expression was investigated in blood cancers using the Oncomine database.
A differential analysis of TDAG8 gene expression was performed between leukemia, lymphoma, and myeloma datasets and normal immune cells and leukocyte-rich tissue. Additional bioinformatics analyses were performed on datasets from the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO). The raw data was downloaded using expression console software HG_u133_Plus_2 and HG_u133a_2 as libraries. The analysis was run and the RMA normalization method was used to generate the values graphed. The output file was then merged with the probe set downloaded from Affymetrix.
Plasmid Constructs
The MSCV-huTDAG8-IRES-GFP construct was made previously and the empty construct, MSCV-IRES-GFP, was used as a control 23 
Cell Lines and Culture
All cell lines were cultured in Roswell Park Memorial Institute medium (RPMI) supplemented with 10% fetal bovine serum (FBS) in a tissue culture incubator set at 37°C and 5.0% CO 2 . RPMI/FBS medium was buffered using 7.5 mM HEPES, 7.5 mM EPPS and 7.5 mM MES, known collectively as RPMI/HEM, as previously described 23 . Cells used for experiments were >95% viable as assessed by the trypan blue dye exclusion method.
To generate green fluorescent protein (GFP) and yellow fluorescent protein (YFP)/luciferase (Luc) cell lines with restored TDAG8 gene expression, retroviral-mediated cell transduction was performed as previously described 28 . To generate the Gα13 signaling-deficient cell lines the p115 Rho RGS construct was subcloned into the pQCXIP vector as previously described 28, 29 . The p115 Rho RGS-pQCXIP and empty pQCXIP retroviral vectors were then stably transduced into U937 cells.
EdU Cell Proliferation Assay
The Click-iT® Plus EdU Imaging Kit was used to examine U937/Vector and U937/TDAG8 cell proliferation. Fluorescence microscopy with the EVOS®fl Digital Inverted Microscope was used to take images of cells incorporating Hoescht® 33342 dye and the EdU analogue, and also images with transmitted light in the same field of view at a 200× magnification. Adobe Photoshop's counting tool was used to count the number of total cells according to Hoescht® 33342 dye and proliferating cells according to EdU positive cells.
Cell Growth Competition Assay
The same number of non-GFP expressing cells (U937/Parental or RPMI 8226/Parental) and GFP expressing cells (Vector or TDAG8) were mixed into a well and the percentages of non-GFP and GFP cells were measured using flow cytometry over 14 days. Cell population percentages were analyzed and graphed.
Annexin V/7AAD Staining
Cells were stained with the PE Annexin V Apoptosis Detection Kit I (BD Biosciences).
Emission of single cell fluorescence was measured at 572 nm for Annexin V, 647 nm for 7AAD, and 525 nm for GFP. The results were analyzed with CellQuest software (BD Biosciences).
Quantitative reverse transcription-polymerase chain reaction (RT-PCR)
Gene expression was determined by quantitative RT-PCR as previously described 23 , using the following TaqMan predesigned primer/probes from Invitrogen, TDAG8 (Hs00269247_s1), c-myc (Hs00153408_m1), and β-actin (Hs99999903_m1). Relative gene expression was calculated using the 2 -ΔΔCt method 30 .
Western Blot
Western blot was performed as previously described 23 . Antibodies of c-myc (product #5605), phospho-paxillin (Y118) (#2541), phospho-CREB (S133) (#9198), CREB (#9197), caspase-3 (#9665), caspase-9 (#9502), cleaved PARP XP (#5625), and β-actin (#4970) were purchased from Cell Signaling Technology.
Histology
Immunohistochemistry for antibodies against c-myc (Abcam, #ab32072), cleaved PARP (Cell Signaling Technology, #5625), Ki67 (Abcam, #ab15580), and human nucleoli (Abcam, #ab190710) was performed on paraffin-embedded 5µm sections. Antigen retrieval was performed by boiling slides in TRIS-EDTA + 0.1% Tween-20 pH 9.0 antigen retrieval buffer for 10-18 minutes. SuperPicture™ 3rd Gen IHC Detection Kit (Invitrogen) was used to complete immunohistochemistry.
Transwell Cell Migration Assays
Two hundred µl of cells were seeded into the transwell insert at 5× 10 6 cells/ml in migration buffer consisting of RPMI media buffered to pH 7.4 and pH 6.4 without FBS and supplemented with 0.1% BSA. Chemoattractant was then added into the bottom well. The plates were then incubated at 37° C and 5% CO 2 for 5 hours. After 5 hours the number of migrated cells was quantified using flow cytometry.
Cell Attachment Assays
Matrigel solution was added into each well to form a thin layer of gel. U937 cells were plated onto Matrigel and incubated at 37°C and 5% CO 2 for 1 hour in culture media buffered to pH 7.4 or 6.4. After 1 hour the media was aspirated and the wells were washed 4 times with RPMI to remove non-adherent cells. For the endothelial cell attachment assay Human Umbilical Vein Endothelial cells (HUVEC) were seeded on 0.1% gelatin-coated plates to create a monolayer. Next, U937 cells were plated in each well in culture media buffered to pH 7.4 or 6.4.
Plates were incubated at 37°C and 5% CO 2 for 1 hour. After 1 hour the media was aspirated and the wells were washed 4 times with RPMI. For all attachment assays several images were taken in various areas of the well to give an adequate representation. Cell attachment was quantified by counting every cell in each field of view.
Primary Tumor and Metastasis Xenograft
NOD.CB17-Prkdc<SCID>/J mice were purchased from Jackson Laboratories and bred at East Carolina University animal facilities for research purposes. All experimental procedures were performed according to institutional regulations. In each experiment, 5× 10 6 U937 or Ramos cells were injected into the flanks of SCID mice. Tumor growth was measured daily using a caliper. Tail vein injections were performed with 2× 10 6 U937 cells in SCID mice. When mice reached endpoint parameters, e.g. lethargy, hunched posture, and unkempt appearance, they were euthanized for analysis. The experiment was terminated 8 months after injection when the remaining mice showed no signs of disease progression. To monitor U937-Luc tumor growth in vivo, intraperitoneal injection with D-Luciferin (Caliper Life Sciences, Catalogue # 119222) at 15 mg/ml in DPBS was performed. Subsequently, mice were imaged using the IVIS Lumina XR unit.
Statistical Analysis
Statistical analysis was performed using the GraphPad Prism software. The unpaired ttest was used to test for statistical significance between 2 groups. Error bars represent ± standard error (S.E.M.) in all graphs. ns P > 0.05, * P < 0.05, ** P < 0.01, *** P < 0.001.
Results
TDAG8 gene expression is reduced significantly in hematologic malignancies in comparison to normal immune cells and leukocyte-rich tissue
Oncomine bioinformatics analysis identified that TDAG8 gene expression was reduced in multiple forms of blood cancer, including acute myeloid leukemia (AML) (2.2 and 6.1 fold) 31, 32 , chronic lymphocytic leukemia (CLL) (3.3, 1.7, 2.3, and 2.6 fold) ( Table 1) (Table 1) 31, 33, 36 . In addition, TDAG8 gene expression is reduced in several lymphomas such as diffuse large B-cell lymphoma (DLBCL) (1.4 and 1.9 fold) 33, 34 , follicular lymphoma (FL) (1.4 and 2.0 fold) 33, 34 , pleural effusion lymphoma (PEL) (2.7 fold) 33 , and Burkitt lymphoma (BL) (1.8 fold) 33 (Table 1) . Lastly, TDAG8 expression was found reduced in smoldering myeloma (SM) (2.6 fold) ( Table 1) 37 . The search in the Oncomine™ Research Premium Edition also revealed various cancer cell lines that were resistant to chemotherapeutics had reduced TDAG8 gene expression in comparison to cancer cell lines that were sensitive to those particular chemotherapeutics ( Table 2) Figure 2A ).
TDAG8 gene expression provides a selective disadvantage to blood cancer cell growth
As TDAG8 gene expression is commonly downregulated in hematological malignancies (Table 1-2 and Figure 1 ), we investigated its function by restoring TDAG8 expression in blood cancer cell lines such as U937, Ramos and RPMI 8226 with low TDAG8 expression. The U937 cell line was originally established from a patient with histiocytic lymphoma and later found to possess characteristics of acute myeloid leukemia (AML) cells 40 . U937 cells were used as a model system for this study because the cells have features of both lymphoma and leukemia.
Proliferation of U937 cells transduced with a construct containing the human TDAG8 gene (U937/TDAG8) was compared to U937 cells transduced with an empty construct (U937/Vector).
The expression level of TDAG8 mRNA in U937/TDAG8 cells was restored to the similar level as that in normal leukocytes ( Figure 2B ). Due to the lack of a reliable TDAG8 antibody, we were unable to detect TDAG8 protein expression. Instead, we examined the TDAG8 downstream signaling activities and found the phosphorylation of CREB was higher in U937/TDAG8 cells than that in U937/Vector cells (Supplemental Figure 1A ), suggesting that restoration of TDAG8 expression augments its downstream G protein signaling. Similarly, CREB phosphorylation was increased in Ramos/TDAG8 cells with the restoration of TDAG8 expression (Supplemental In comparison to U937/Vector cells, U937/TDAG8 cells proliferated 7% less (47.8% vs. 40 .5% proliferating cells) at physiological pH 7.4 ( Figure 2B -C). When U937/Vector cells were treated with pH 6.9, there was a 10% increase in cell proliferation in comparison to physiological pH 7.4. However, restoring TDAG8 gene expression sensitized U937 cells to media buffered to pH 6.9 and suppressed cell proliferation at pH 6.9 ( Figure 2C ). Severe acidosis, pH 6.4, significantly reduced cell proliferation in both U937/Vector and U937/TDAG8 cells ( Figure 2C ).
Next, cell growth competition assays were performed to demonstrate negative selection of U937 cells expressing the TDAG8 gene. In the cell growth competition assay there was a slight change in the U937/Parental-U937/Vector cell populations (50 ±5%) after 14 days ( Figure   2D ). However, the U937/TDAG8 cell population was only 30% of the total population of cells in comparison to 70% of the U937/Parental cells at pH 7.4 ( Figure 2E ). Quantitative RT-PCR also demonstrated that restoration of TDAG8 expression in U937/TDAG8 cells reduced the expression of c-myc oncogene on day 0 and day 14 of the competition assay in comparison to the U937/Vector cells (Supplemental Figure 2A-B ). The growth competition assay was also performed in medium buffered to mildly acidic pH 6.9. The U937/TDAG8 cell population was significantly reduced to 23% of the total population of cells at pH 6.9 ( Figure 2H ). The U937/Vector and U937/Parental cells showed slight changes (50 ±5%) relative to each other at pH 6.9 ( Figure 2G ). Results were similar when the competition assay was performed with the RPMI 8226/Vector and RPMI 8226/TDAG8 myeloma cells (Supplemental Figure 3 ).
The GFP mean fluorescence value remained stable from day 0 to day 14 with little variation in the U937/Vector cells when co-cultured with the U937/Parental cells (Supplemental Figure 2C ). However, U937/TDAG8 cell GFP mean fluorescence value as an indicator of TDAG8 transgene expression was considerably reduced (Supplemental Figure 2C ). When comparing day 0 with day 14 at pH 6.9 there was a 65% reduction in GFP mean fluorescence value of U937/TDAG8 cells (Supplemental Figure 2D ).
Annexin V PE/7AAD staining was performed at day 7 and day 14 of the competition assay to examine U937 cell apoptosis. It was determined there was a significant increase of apoptosis in U937/TDAG8 cells in comparison to U937/Parental cells at pH 7.4 and at pH 6.9
( Figure 2F & I). Increased apoptosis of U937/TDAG8 cells also correlated with an increase in caspase 3, caspase 9, and PARP cleavage (Supplemental Figure 4 ).
Restoration of TDAG8 gene expression reduces primary tumor growth in severe combined immunodeficient (SCID) mice
U937 cells were originally isolated from a patient with histiocytic lymphoma and can form solid tumors, which are known to be spatially acidic. To determine the effects of restoring TDAG8 gene expression on U937 primary tumor growth, subcutaneous xenograft experiments were performed in SCID mice. A significant inhibition of U937/TDAG8 tumor growth was observed throughout the experiments ( Figure 3A ). In addition, overall tumor mass was reduced by ~50% in U937/TDAG8 tumors ( Figure 3B ). Similar trends were found following Ramos/Vector and Ramos/TDAG8 lymphoma cell injections into SCID mice (Supplemental Figure 5 ). In vivo luminescence imaging was also used to visualize tumor growth over 2 weeks.
The pattern previously observed in U937/TDAG8 cells, i.e. reduced tumor growth, was consistent with the U937/TDAG8-Luc cells expressing TDAG8 and the luciferase marker gene ( Figure 3C ).
Tumor acidosis congruent to necrotic regions inhibits c-myc expression
Immunohistochemistry (IHC) of c-myc expression revealed that sections nearest necrotic regions of tumors, known to be acidic 17 
Acidosis stimulates Gα13/RhoA signaling and reduces c-myc expression in U937 cells partially through TDAG8
IHC analysis of c-myc protein expression revealed that U937/TDAG8 tumor cells expressed lower levels of c-myc in comparison to U937/Vector control ( Figure 4B ). It was also qualitatively determined that c-myc expression was undetectable in numerous U937/TDAG8 cells ( Figure 4B ). In comparison, the majority of U937/Vector cells expressed c-myc at a high level ( Figure 4A ). It was also determined that restoring TDAG8 gene expression reduces c-myc protein expression significantly in comparison to the U937/Vector control cells at physiological These observations are consistent with previous studies showing that TDAG8 has some constitutive activities at the physiological pH and is fully activated under acidic pH 41 .
Following inhibition of Gα13 signaling by the p115 RGS construct 28, 29 , Western blot analysis determined that c-myc expression was restored in the U937/TDAG8 cells after treatment with media buffered to pH 7.4 and pH 6.4 ( Figure 4E Figure   6 ). Therefore, the data suggests TDAG8 exerts its growth inhibitory effects through activation of Gα13/RhoA signaling in U937 cells.
Restoration of TDAG8 gene expression in U937 cells reduces cell attachment and migration correlating with altered focal adhesion dynamics
Restoration of TDAG8 gene expression reduced the ability for U937 cells to attach to Matrigel at physiological pH 7.4 by more than 50% ( Figure 5A ). Activation of TDAG8 by extracellular acidosis reduced U937 cell attachment even further demonstrating the antimetastatic capabilities of TDAG8 ( Figure 5A ). U937 cell attachment to a HUVEC monolayer was also investigated revealing a reduction in U937/TDAG8 cell attachment to endothelial cells at physiological pH 7.4 and acidic pH 6.4 (Supplemental Figure 7A ). However, overall cell attachment to a HUVEC monolayer was increased at acidic pH 6.4 likely due to the effects of acidosis on endothelial cell-mediated attachment 42 . It was also determined that U937/TDAG8-Luc cells exhibited less cell migration towards the chemoattractant SDF-1α in comparison to U937/Vector-Luc cells ( Figure 5B ). In addition, treatment with pH 6.4 further reduced the migration of U937/TDAG8-Luc cells in comparison to the U937/Vector-Luc cells ( Figure 5B ).
This was also observed in the U937 cells that were transduced with the GFP construct (Supplemental Figure 7B ).
Increased activity of focal adhesion proteins such as focal adhesion kinase (FAK) and
paxillin have been correlated with poor patient survival and increased malignancy of blood and other cancers [43] [44] [45] [46] [47] [48] . We found that restoring TDAG8 gene expression in U937 cells significantly inhibited the phosphorylation of paxillin Y118 at pH 7.4 and pH 6.4 ( Figure 5C-D) , suggesting a reduced activity of the FAK/paxillin pathway 49,50 . In addition, when treated with media buffered to pH 6.4 the phosphorylation of paxillin Y118 was reduced in comparison to the pH 7.4 treatment groups ( Figure 5C-D) .
Restoration of TDAG8 gene expression in U937 cells reduces metastasis in SCID mice following tail vein injections
Overall, the in vivo imaging of SCID mice was not sensitive enough to visualize micrometastasis of tumor cells ( Figure 6A Figure 7C ). To further quantify metastasis, the mouse lungs were analyzed using an anti-human nucleoli antibody specific for human cells (Figure 6B-E) . The results indicate the severity of U937 cell metastasis to the lung of SCID mice was significantly reduced by restoring TDAG8 expression ( Figure 6F ).
Discussion
The effect of extracellular acidosis on cancer progression is complex; therefore it is important to understand the cancer cell biological response to it 13 . In this study it was determined that diverse extremities of extracellular acidosis had differential effects on cellular proliferation ( Figure 2C -E & G-H). It was clearly demonstrated that mild extracellular acidosis, pH 6.9, increased U937 cell proliferation while severe acidosis, pH 6.4, repressed it ( Figure 2C ).
In addition, this report evaluated the effects of tumor acidosis on c-myc oncogene expression in vivo. In tumor sections nearest necrotic regions, known to be acidic 17 , c-myc oncogene expression was reduced significantly in live tumor cells ( Figure 3D -I). However, invasive cancer cells that were invading new tissue, devoid of blood vessels and nutrients, did not follow this pattern ( Figure 3D-I) . Conversely, invasive tumor cells had increased expression of c-myc and Ki-67 signifying they are actively proliferating and invasive despite extracellular acidosis and nutrient deprivation ( Figure 3D-I) . The discovered pattern of tumor cell invasiveness in harsh extracellular conditions concurrently associating with increased cell proliferative markers is similar to an acid resistant phenotype described previously 17, 18 . Importantly, understanding that extracellular acidosis reduces c-myc oncogene expression in some tumor cells while not in others provides an original understanding for the heterotypic and spatial tumor cell response to extracellular acidosis. To understand how tumor cells sense extracellular acidosis the proton sensing G-protein coupled receptor TDAG8 was investigated.
TDAG8 has been reported to have a diverse repertoire of pro-and anti-oncogenic effects that are cell type and context dependent [22] [23] [24] [51] [52] [53] [54] . The data provided in this study indicates that TDAG8 gene expression is suppressive for U937 cell malignancy. It was discovered that TDAG8 gene expression is reduced in the majority of blood cancers in comparison to normal immune cells or leukocyte-rich tissue (Table 1 & Figure 1 ). In addition, higher expression of the TDAG8 gene correlates with increased sensitivity toward various chemotherapeutics (Table 2) .
Using U937 acute myeloid leukemia cells as a model system TDAG8 gene expression was restored to a normal physiological level to test the hypothesis that TDAG8 gene expression provides a disadvantage for blood cancer cell malignancy. Restoring TDAG8 gene expression in Figure 4A-C) 23 . This is consistent with previous results demonstrating that TDAG8 exhibits constitutive activity at physiological pH and is further activated at acidic pH 41 . Moreover, the results from this report indicate that the inhibitory effects of acidosis on c-myc oncogene expression are partially due to TDAG8-mediated Gα13/RhoA signaling ( Figure 4D -E). This idea aligns with recent reports that demonstrate Gα13/RhoA signaling suppresses oncogenesis and acts as a tumor suppressor in lymphoma 55,56 . Overall, it is hypothesized in this report that extracellular acidosis provides a selective pressure against cancer cells, which modulates clonal cell evolution. Moreover, TDAG8 is a proton sensor that plays an important role in this process, which has important implications for blood cancer progression as well as cancer cell clonal evolution parallel to extracellular acidosis found within the tumor microenvironment. Mice with < 2 average metastatic lesions in each 5 µm section of the lung were given a score of 1, from 2-5 average metastatic lesions were given a score of 2, from 6-10 average metastatic lesions were given a score of 3, and from 11 or more average metastatic lesions were given a score of 4. In addition, lesions that were larger than 20 cells or large enough to see with the IVIS Lumina XR unit was given a 4. 
